NEU 0.30% $13.14 neuren pharmaceuticals limited

NEU is materially undervalued, page-81

  1. 391 Posts.
    lightbulb Created with Sketch. 44
    Lol. Ignore if you want. I'm very positive long term, disappointed short term. Initially I was very pleased the with FDA update, but still disappointed by the lack of clarity. That is still the case
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.